TSHA
Taysha Gene Therapies Inc
4.40$
+0.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -24.1% | -5.4% | -67.4% | +60.8% | +13.1% | +13.8% | -13.7% | -100.0% | – | -100.0% | – | – | |
| – | +10.6% | -11.2% | -7.7% | – | – | – | – | +3.2% | +4.5% | -1.3% | – | – | |
| – | -18.4% | -5.4% | -67.4% | +60.8% | +13.1% | +13.8% | -13.7% | -114.4% | – | -105.7% | – | – | |
| – | +7.6% | +62.9% | -27.0% | -0.8% | +2.5% | +1.6% | +29.4% | +26.4% | -3.2% | +37.1% | +14.3% | – | |
| – | -21.8% | +5.4% | +3.6% | +7.7% | -16.1% | +23.1% | +5.4% | -3.7% | +6.7% | +9.6% | +25.5% | – | |
| – | -1.0% | +39.8% | -19.2% | +23.5% | -20.7% | +8.1% | +21.1% | +17.4% | -0.7% | +29.0% | +9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -51.5% | -95.9% | -6.9% | -11.1% | -8.3% | -13.6% | -10.5% | -11.8% | -20.0% | -25.0% | -33.3% | – | |
| – | – | -150.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -150.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -148.6% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.